Will Keep Seroquel Settlement Terms Confidential
Plc, which tentatively settled almost 4,000 product-liability cases this
month involving its antipsychotic drug Seroquel through mediation, said
it will keep terms of the agreements confidential.
remains committed to a strong defense effort, but will also continue to
participate in good faith in the court-ordered mediation process,”
Tony Jewell, an AstraZeneca U.S. spokesman in Wilmington, Delaware, said
yesterday in an e-mailed statement.
company, the U.K.’s second-biggest drugmaker, said in a regulatory
filing that by the end of March, it was defending more than 10,000 cases
involving 22,500 plaintiff groups. Some of the cases were previously dismissed
because plaintiffs lacked sufficient evidence to support allegations that
Seroquel causes diabetes.
with $32.8 billion in sales last year, said in the July 29 filing that by
March, it had spent about $688 million defending Seroquel-related cases.
agreed earlier to pay $2 million to settle more than 200 Seroquel cases,
averaging about $10,000 each, people familiar with the agreements said.
Those settlements were part of the same federal-court-ordered mediation.
of the cases were filed in state courts, including New Jersey and Delaware.
Others have been consolidated on the federal level with U.S. District Judge
Anne Conway in Orlando, Florida.
first Seroquel case to be tried, AstraZeneca won a jury verdict that the
company properly warned doctors of a Vietnam War veteran of the drug’s
diabetes risk. A judge in Delaware dismissed three more cases saying there
wasn’t enough proof of a diabetes link.
Seroquel case is In re Seroquel Products Litigation, 06-MD-01769, U.S. District
Court, Middle District of Florida (Orlando).
the reporters on this story: Phil Milford in Wilmington, Delaware, at email@example.com;
Jef Feeley in Wilmington at firstname.lastname@example.org.
on this story: http://gulfnews.com/business/general/seroquel-terms-to-be-kept-secret-1.662153